"GLOW"
GHK-Cu + BPC-157 + TB-500 — the skin-and-recovery sibling of the healing-blend family.
Evidence tier C · Not approved in Canada · Community risk: high — premixed, unverifiable, and sold as a finished "aesthetic" product.
C
What it is
GLOW is a community-named, usually premixed injectable blend of GHK-Cu + BPC-157 + TB-500, marketed for skin quality, collagen, "glow," and general recovery. Unlike a DIY stack, it's typically sold as a ready-mixed multi-peptide vial under grey-market brand names. It shares BPC-157 + TB-500 with the Wolverine stack — Wolverine is the injury-recovery framing of the same core; GLOW is the skin framing.
What People Use it For
• Skin appearance, "glow," and anti-aging.
• Post-procedure recovery and general soft-tissue healing.
• The aesthetic-positioned member of the healing-blend family (Wolverine = injury, GLOW = skin, KLOW = skin + inflammation).
What The Evidence Shows
Each component is Tier C on its own: GHK-Cu has real topical skin data but unsupported injected/systemic use; BPC-157 is animal-data-only with an empty Phase 1; TB-500's literature is mostly endogenous thymosin β4 biology, not trials of the injected compound.
The combination has zero human trials. Every GLOW claim is inferred from thin single-compound data plus anecdote. Additive benefit is assumed, not shown; additive risk is equally unstudied.
There's a specific irony here: for skin, topical GHK-Cu has better evidence than injecting it — so the blend takes on injection and blend risk for a use the topical route already addresses more safely.
Regulatory Status - Canada
None of GHK-Cu, BPC-157, or TB-500 is a Health-Canada-approved therapeutic. A premixed GLOW vial is an unapproved, unverified product regardless of what the label says. US context: BPC-157 and thymosin β4/TB-500 are on the agenda for the FDA's Pharmacy Compounding Advisory Committee (July 23–24, 2026), but that's a US compounding-list question and doesn't change Health Canada status or make any blend approved.
Risks & Red Flags
• Premixed = unverifiable and un-adjustable: you can't confirm any single component's dose, can't attribute a reaction to one ingredient, and can't change the ratio.
• Pro-angiogenic concern (BPC-157 / TB-500) — relevant for anyone with cancer risk.
• Copper load (GHK-Cu) with repeated injected use, unquantifiable in an unverified blend.
• Self-injection sterility and reconstitution-math error.
The Honest Bottom Line
GLOW sells a look — literally. The branding is aesthetic, the promise is "glow," and that framing makes it feel lower-stakes than an injury or hormone protocol. It isn't. You're injecting three unapproved compounds, premixed by an unregulated maker, for a benefit no combination trial has ever measured — and for the skin goal specifically, the topical version of one ingredient has better support than the needle. If the aesthetic pull is what's driving the decision, that's the strongest reason to slow down.
How To Lower Your Risk
• Single compounds over premixed blends if using at all — at least each dose is knowable and reactions are attributable.
• For skin specifically, topical GHK-Cu has better support than injected — consider whether the injectable blend's added risk is buying you anything.
• Third-party identity + quantity testing (not a vendor "99% purity" claim) is the minimum sourcing bar.
• Sterile technique; never share vials; watch for injection-site infection.
• Talk to a clinician; watch the delayed-care trap if "skin/recovery" is masking something that needs assessment.
• Learn the slang glossary so you know what's actually in a blend before it's in you..
Sources
• Component evidence: see the BPC-157, TB-500, and GHK-Cu pages (this project).
• Combination: no human trials identified.
• Mislabeling / Glow-Klow swaps: grey-market testing and pharmacist commentary (this project's community-discourse memo).
Substrate is an independent educational harm-reduction resource. It is not medical, legal, or regulatory advice, and it is not a substitute for a licensed clinician. Compounds discussed are largely unapproved in Canada; nothing here endorses their use. Confirm anything health-related with a qualified professional. Built by a medical-sciences student — not a seller and not a clinic.